Inogen Inc (INGN) research
Inogen Inc- Sector
- Health Care
- Last price
- $5.97
- As of
Inogen Inc (INGN): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-30.
As of . Source: SEC EDGAR filings for INGN. Method and limitations.
Share the INGN intelligence card
See the full INGN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for INGN on one page. Preview it with sample data, then open it live with a free account.
Preview the INGN dossierActive signals for INGN
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 10.9%, EPS $-0.14 vs $-0.1571 estimate
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 73% of INGN (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 73% of INGN (2026Q2)
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +218% to INGN (2026Q1)
- mediumNEW_POSITION
D. E. Shaw & Co., Inc. new position in INGN
FREE, NO ACCOUNT
Every signal on INGN, as it fires
You are seeing 5 of 10 signals recorded on INGN since 2026-05-31.
The five above landed across 2 days. The other 5 were recorded on 2 other days. 5 of the 10 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in INGN (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 45780L104 · 2026Q2 | $3.1M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 45780L104 · 2026Q2 | $1.1M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 45780L104 · 2026Q2 | $240K | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 45780L104 · 2026Q2 | $152K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 45780L104 · 2026Q2 | $97K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, INGN
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
INGN against its peers
INGN's operating margin of -10.2% ranks in the 48th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-08-31 and 2026-05-31.
| Metric | INGN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 295M USD | 323M USD | 37 | 25 |
| Gross margin | 52.2% | 65.7% | 18 | 13 |
| Operating margin | -10.2% | -8.0% | 48 | 25 |
| Net margin | -7.7% | -9.0% | 60 | 25 |
| Return on equity | -11.8% | -14.5% | 56 | 23 |
Peers (25): RXST, DH, CTEV, SLP, EVH, CCRN, CERS, SGHT, FLGT, ANGO, ACH, EHAB, AHCO, VREX, TALK, HSTM, BVS, PRCT, TDOC, CSTL, IRMD, GDRX, STAA, TNDM, OMDA. Fiscal periods ending between 2025-08-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (INGN: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more INGN signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to INGNand get the insider, 13F, options, and confluence read in one view.